Skip to Main Content

Paper Details

The mRNA vaccine BNT162b2 demonstrates impaired T<sub>H</sub>1 immunogenicity in human elders <i>in vitro</i> and aged mice <i>in vivo</i>.
Res Sq
0
2022
APOC2, APOF, BNT162b2, C1S, CPN1, CXCL10, Elder T1 impairment, IFN, PI16, PSMC6, SARS-CoV-2, T1, TPM4, age, elder blood, human, mRNA, mice, participants
Author NameAffiliation
Matthew B FriemanCenter for Pathogen Research, The University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, The University of Maryland School of Medicine
Al OzonoffBoston Children's Hospital
Al OzonoffHarvard Medical School
Hanno SteenBoston Children's Hospital
Hanno SteenBoston Children's Hospital, Harvard Medical School
Hanno SteenBoston Children's Hospital
Hanno SteenBoston Children's Hospital, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2